132 related articles for article (PubMed ID: 38514271)
1. [Research progress of long-chain non-coding RNA in lipid metabolism reprogramming in primary hepatocellular carcinoma].
Yu Z; Chen DM; Huang JL
Zhonghua Gan Zang Bing Za Zhi; 2024 Feb; 32(2):180-185. PubMed ID: 38514271
[TBL] [Abstract][Full Text] [Related]
2. The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma.
Liao W; Du J; Wang Z; Feng Q; Liao M; Liu H; Yuan K; Zeng Y
Int J Cancer; 2022 Aug; 151(3):337-347. PubMed ID: 35460073
[TBL] [Abstract][Full Text] [Related]
3. A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression.
Xu K; Xia P; Gongye X; Zhang X; Ma S; Chen Z; Zhang H; Liu J; Liu Y; Guo Y; Yao Y; Gao M; Chen Y; Zhang Z; Yuan Y
Mol Metab; 2022 Sep; 63():101540. PubMed ID: 35798238
[TBL] [Abstract][Full Text] [Related]
4. Lipid metabolism-related long noncoding RNA RP11-817I4.1 promotes fatty acid synthesis and tumor progression in hepatocellular carcinoma.
Wang RY; Yang JL; Xu N; Xu J; Yang SH; Liang DM; Li JZ; Zhu H
World J Gastroenterol; 2024 Feb; 30(8):919-942. PubMed ID: 38516243
[TBL] [Abstract][Full Text] [Related]
5. Emerging roles and potential clinical applications of long non-coding RNAs in hepatocellular carcinoma.
Sheng J; Lv E; Xia L; Huang W
Biomed Pharmacother; 2022 Sep; 153():113327. PubMed ID: 35779423
[TBL] [Abstract][Full Text] [Related]
6. Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway.
Xu M; Zhou C; Weng J; Chen Z; Zhou Q; Gao J; Shi G; Ke A; Ren N; Sun H; Shen Y
J Exp Clin Cancer Res; 2022 Aug; 41(1):253. PubMed ID: 35986343
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA LINC01234 promotes hepatocellular carcinoma progression through orchestrating aspartate metabolic reprogramming.
Chen M; Zhang C; Liu W; Du X; Liu X; Xing B
Mol Ther; 2022 Jun; 30(6):2354-2369. PubMed ID: 35192933
[TBL] [Abstract][Full Text] [Related]
8. Functional roles of lncRNA-TUG1 in hepatocellular carcinoma.
Farzaneh M; Ghasemian M; Ghaedrahmati F; Poodineh J; Najafi S; Masoodi T; Kurniawan D; Uddin S; Azizidoost S
Life Sci; 2022 Nov; 308():120974. PubMed ID: 36126725
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation.
Ding H; Liu J; Zou R; Cheng P; Su Y
J Exp Clin Cancer Res; 2019 May; 38(1):189. PubMed ID: 31072375
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
12. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
13. The role of long non-coding RNA in hepatocellular carcinoma.
Liang W; Zhao Y; Meng Q; Jiang W; Deng S; Xue J
Aging (Albany NY); 2024 Feb; 16(4):4052-4073. PubMed ID: 38334963
[TBL] [Abstract][Full Text] [Related]
14. RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4.
Wang C; Chen Z; Yi Y; Ding Y; Xu F; Kang H; Lin K; Shu X; Zhong Z; Zhang Z; Liu J; Xu Z; Liu L; He X; Chang Y; Zhao Q
Oncogene; 2024 Jan; 43(5):328-340. PubMed ID: 38040804
[TBL] [Abstract][Full Text] [Related]
15. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.
Song W; Zhang J; Xia Q; Sun M
Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201
[No Abstract] [Full Text] [Related]
16. Long noncoding RNA RP11-909N17.2 promotes proliferation, invasion, and migration of hepatocellular carcinoma by regulating microRNA-767-3p.
Liu Q; Dai SJ; Dong L; Li H
Biochem Cell Biol; 2020 Dec; 98(6):709-718. PubMed ID: 33210543
[TBL] [Abstract][Full Text] [Related]
17. LncRNA FIRRE promotes the proliferation and metastasis of hepatocellular carcinoma by regulating the expression of PXN through interacting with MBNL3.
Zhou J; Liu T; Xu H; Wang Y; Yang T; Liu L
Biochem Biophys Res Commun; 2022 Oct; 625():188-195. PubMed ID: 35988459
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
19. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2.
Jin L; He Y; Tang S; Huang S
J Cell Physiol; 2018 Jun; 233(6):4726-4734. PubMed ID: 29139562
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis.
Zhang M; Wang W; Li T; Yu X; Zhu Y; Ding F; Li D; Yang T
Biomed Pharmacother; 2016 May; 80():73-79. PubMed ID: 27133041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
